NYSE
ABBV

AbbVie Inc

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

AbbVie Inc Stock Price

Vitals

Today's Low:
$144.4800
Today's High:
$148.0800
Open Price:
$147.0300
52W Low:
$110.7
52W High:
$171.07
Prev. Close:
$146.9100
Volume:
5345330

Company Statistics

Market Cap.:
$255.526 billion
Book Value:
8.29
Revenue TTM:
$57.819 billion
Operating Margin TTM:
38.2%
Gross Profit TTM:
$38.883 billion
Gross Profit TTM:
$38.883 billion
Profit Margin:
23.2%
Return on Assets TTM:
8.14%
Return on Equity TTM:
92.7%

Company Profile

AbbVie Inc had its IPO on 2013-01-02 under the ticker symbol ABBV.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. AbbVie Inc has a staff strength of 0 employees.

Stock update

Shares of AbbVie Inc opened at $147.03 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $144.48 - $148.08, and closed at $144.52.

This is a -1.63% slip from the previous day's closing price.

A total volume of 5,345,330 shares were traded at the close of the day’s session.

In the last one week, shares of AbbVie Inc have slipped by -3.65%.

AbbVie Inc's Key Ratios

AbbVie Inc has a market cap of $255.526 billion, indicating a price to book ratio of 17.73 and a price to sales ratio of 4.419.

In the last 12-months AbbVie Inc’s revenue was $57.819 billion with a gross profit of $38.883 billion and an EBITDA of $30.212 billion. The EBITDA ratio measures AbbVie Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, AbbVie Inc’s operating margin was 38.2% while its return on assets stood at 8.14% with a return of equity of 92.7%.

In Q3, AbbVie Inc’s quarterly earnings growth was a positive 24.2% while revenue growth was a positive 3.3%.

AbbVie Inc’s PE and PEG Ratio

Forward PE
12.95
Trailing PE
19.27
PEG
1.279

Its diluted EPS in the last 12-months stands at $7.5 per share while it has a forward price to earnings multiple of 12.95 and a PEG multiple of 1.279. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into AbbVie Inc’s profitability.

AbbVie Inc stock is trading at a EV to sales ratio of 5.58 and a EV to EBITDA ratio of 19.06. Its price to sales ratio in the trailing 12-months stood at 4.419.

AbbVie Inc stock pays annual dividends of $5.64 per share, indicating a yield of 4.1% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

AbbVie Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

AbbVie Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

AbbVie Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, AbbVie Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, AbbVie Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$144.52
52-Week High
$171.07
52-Week Low
$110.7
Analyst Target Price
$157.04

AbbVie Inc stock is currently trading at $144.52 per share. It touched a 52-week high of $171.07 and a 52-week low of $171.07. Analysts tracking the stock have a 12-month average target price of $157.04.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About AbbVie Inc

The stock symbol (also called stock or share ticker) of AbbVie Inc is ABBV

The IPO of AbbVie Inc took place on 2013-01-02

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$42.27
0.05
+0.12%
$170.43
-2.66
-1.54%
$310.01
-4.19
-1.33%
$55.33
-0.41
-0.74%
$98.04
-1.27
-1.28%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.

Address

1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US